Insider · CIK 0001574558

Lis William

Reports to the SEC for 4 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001574558

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-12	ZLABZai Lab LtdS Sale	Director	SSale	−8,506 sh	$25.00	−$213K	41,931
2026-06-22	ZLABZai Lab LtdS Sale	Director	SSale	−7,040 sh	$18.09	−$127K	50,437
2026-06-17	ZLABZai Lab LtdA Award	Director	AAward	+22.4K sh	—	—	57,477
2025-06-20	ZLABZai Lab LtdS Sale	Director	SSale	−13.8K sh	$35.67	−$493K	35,106
2025-06-18	ZLABZai Lab LtdA Award	Director	AAward	+10.8K sh	—	—	48,920
2025-02-28	ZLABZai Lab LtdS Sale	Director	SSale	−15K sh	$32.98	−$495K	38,089
2024-07-01	ZLABZai Lab LtdS Sale	Director	SSale	−10.3K sh	$17.31	−$178K	53,189
2024-07-01	ZLABZai Lab LtdS Sale	Director	SSale	−100 sh	$18.04	−$1,804	53,089
2024-06-18	ZLABZai Lab LtdA Award	Director	AAward	+21.3K sh	—	—	63,486
2023-10-13	JSPRJasper Therapeutics, Inc.S Sale	Director	SSale	−7,965 sh	$0.85	−$6,776.622	53,521
2023-06-29	ZLABZai Lab LtdA Award	Director	AAward	+18.9K sh	$26.45	+$500K	42,233
2023-06-07	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+47K sh	—	—	47,000
2023-04-13	JSPRJasper Therapeutics, Inc.S Sale	Director	SSale	−8,500 sh	$1.44	−$12.2K	61,486
2023-03-03	ZLABZai Lab LtdS Sale	Director	SSale	−5,434 sh	$38.31	−$208K	23,330
2022-10-12	JSPRJasper Therapeutics, Inc.A Award	Director	AAward	+29.5K sh	—	—	69,986
2022-06-27	JSPRJasper Therapeutics, Inc.S Sale	Director	SSale	−24.7K sh	$2.08	−$51.4K	40,486
2022-06-24	JSPRJasper Therapeutics, Inc.S Sale	Director	SSale	−24.7K sh	$2.02	−$50K	65,229
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+90K sh	—	—	89,972
2022-03-21	JSPRJasper Therapeutics, Inc.A Award	Director	AAward	+90K sh	—	—	89,972
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+100K sh	—	—	100,000
2022-03-21	JSPRJasper Therapeutics, Inc. · Stock Option (right to buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2022-01-20	ZLABZai Lab LtdS Sale	Director	SSale	−1,926 sh	$53.40	−$103K	34,114
2022-01-03	ZLABZai Lab LtdA Award	Director	AAward	+7,763 sh	—	—	36,040
2021-01-26	Eidos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.5K sh	—	—	0
2021-01-26	Eidos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−21.5K sh	—	—	0
2021-01-26	Eidos Therapeutics, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−43.1K sh	—	—	0
2021-01-15	ZLABZai Lab LtdA Award	Director	AAward	+3,852 sh	—	—	28,277
2021-01-05	ZLABZai Lab LtdF Tax Payment	Director	FTax Payment	−5,350 sh	$129.14	−$691K	22,927
2020-05-27	Eidos Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,528
2019-06-12	Eidos Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+21.5K sh	—	—	21,528
2018-12-04	Eidos Therapeutics, Inc.Stock Option (right to buy)A Award	Director	AAward	+43.1K sh	—	—	43,056
2018-08-23	PORTOLA PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−17.6K sh	$26.05	−$458K	204,448
2018-07-28	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+35K sh	—	—	222,035
2018-06-06	PORTOLA PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−5,113 sh	$45.21	−$231K	222,035
2018-05-22	PORTOLA PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−6,491 sh	$40.82	−$265K	227,148
2018-05-22	PORTOLA PHARMACEUTICALS INCA Award	Director, Chief Executive Officer	AAward	+12.9K sh	—	—	233,639
2018-03-02	PORTOLA PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−19.2K sh	$32.53	−$624K	70,624
2018-01-31	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2018-01-31	PORTOLA PHARMACEUTICALS INCA Award	Director, Chief Executive Officer	AAward	+25K sh	—	—	25,000
2017-08-16	PORTOLA PHARMACEUTICALS INCF Tax Payment	Director, Chief Executive Officer	FTax Payment	−7,435 sh	$54.86	−$408K	0
2017-06-28	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−14.2K sh	—	—	101,820
2017-06-28	PORTOLA PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−14.2K sh	$55.35	−$783K	0
2017-06-28	PORTOLA PHARMACEUTICALS INCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+14.2K sh	$9.00	+$127K	14,150
2017-06-27	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−20K sh	—	—	69,796
2017-06-27	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−70K sh	—	—	0
2017-06-27	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−14.3K sh	—	—	0
2017-06-27	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−55K sh	—	—	2,070
2017-06-27	PORTOLA PHARMACEUTICALS INCStock Option (Right to Buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−95.9K sh	—	—	115,970
2017-06-27	PORTOLA PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−13.1K sh	$56.57	−$741K	0
2017-06-27	PORTOLA PHARMACEUTICALS INCS Sale	Director, Chief Executive Officer	SSale	−113K sh	$55.90	−$6.3M	13,100

Recent filings

Accepted (ET)
Aug 134
Lis William0000905148-26-003620
SEC(opens sec.gov)
Jun 244
Lis William0000905148-26-003077
SEC(opens sec.gov)
Jun 224
Lis William0000905148-26-003031
SEC(opens sec.gov)
Jun 234
Lis William0000905148-25-002215
SEC(opens sec.gov)
Mar 44
Lis William0000905148-25-000827
SEC(opens sec.gov)
Jul 34
Lis William0000905148-24-001839
SEC(opens sec.gov)
Jun 204
Lis William0000905148-24-001748
SEC(opens sec.gov)
Oct 134
Lis William0001013762-23-003901
SEC(opens sec.gov)
Jun 304
Lis William0000950170-23-031097
SEC(opens sec.gov)
Jun 84
Lis William0001213900-23-047568
SEC(opens sec.gov)
Apr 144
Lis William0001213900-23-029888
SEC(opens sec.gov)
Mar 74
Lis William0000899243-23-007333
SEC(opens sec.gov)
Oct 134
Lis William0001213900-22-063936
SEC(opens sec.gov)
Jun 284
Lis William0001213900-22-035570
SEC(opens sec.gov)
Mar 234
Lis William0001213900-22-014562
SEC(opens sec.gov)

Companies

Address

C/O ZAI LAB LIMITED 314 MAIN STREET, 4TH FLOOR, SUITE 100

CAMBRIDGE, MA, 02142